Risk Analysis of Respiratory Syncytial Virus Among Infants in the United States by Birth Month

被引:0
|
作者
Gantenberg, Jason R. [1 ,2 ]
van Aalst, Robertus [1 ,3 ,4 ]
Bhuma, Monika Reddy [1 ]
Limone, Brendan [5 ]
Diakun, David [5 ]
Smith, David M. [5 ]
Nelson, Christopher B. [6 ]
Bengtson, Angela M. [7 ]
Chaves, Sandra S. [3 ]
La Via, William V. [6 ]
Rizzo, Christopher [6 ]
Savitz, David A. [2 ]
Zullo, Andrew R. [1 ,2 ,8 ]
机构
[1] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, 200 Dyer St, BU Box 2013, Providence, RI 02903 USA
[2] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI USA
[3] Sanofi, Vaccines Med Affairs, Dept Modeling Epidemiol & Data Sci, Lyon, France
[4] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Groningen, Netherlands
[5] Merative, Cambridge, MA USA
[6] Vaccines Med Affairs, Sanofi, Swiftwater, PA USA
[7] Emory Univ, Dept Epidemiol, Atlanta, GA USA
[8] Providence VA Med Ctr, Providence, RI USA
关键词
birth month; descriptive epidemiology; infants; lower respiratory tract infection; respiratory syncytial virus; YOUNG-CHILDREN; HOSPITALIZATION; SEASONALITY; PREVENTION; INFECTION; COVID-19; BRONCHIOLITIS; NIRSEVIMAB; MORTALITY; PRETERM;
D O I
10.1093/jpids/piae042
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Respiratory syncytial virus (RSV) is a major cause of morbidity and mortality among US infants. A child's calendar birth month determines their age at first exposure(s) to RSV. We estimated birth month-specific risk of medically attended (MA) RSV lower respiratory tract infection (LRTI) among infants during their first RSV season and first year of life (FYOL).Methods We analyzed infants born in the USA between July 2016 and February 2020 using three insurance claims databases (two commercial, one Medicaid). We classified infants' first MA RSV LRTI episode by the highest level of care incurred (outpatient, emergency department, or inpatient), employing specific and sensitive diagnostic coding algorithms to define index RSV diagnoses. In our main analysis, we focused on infants' first RSV season. In our secondary analysis, we compared the risk of MA RSV LRTI during infants' first RSV season to that of their FYOL.Results Infants born from May through September generally had the highest risk of first-season MA RSV LRTI-approximately 6-10% under the specific RSV index diagnosis definition and 16-26% under the sensitive. Infants born between October and December had the highest risk of RSV-related hospitalization during their first season. The proportion of MA RSV LRTI events classified as inpatient ranged from 9% to 54% (specific) and 5% to 33% (sensitive) across birth month and comorbidity group. Through the FYOL, the overall risk of MA RSV LRTI is comparable across birth months within each claims database (6-11% under the specific definition, 17-30% under the sensitive), with additional cases progressing to care at outpatient or ED settings.Conclusions Our data support recent national recommendations for the use of nirsevimab in the USA. For infants born at the tail end of an RSV season who do not receive nirsevimab, a dose administered prior to the onset of their second RSV season could reduce the incidence of outpatient- and ED-related events.
引用
收藏
页码:317 / 327
页数:11
相关论文
共 50 条
  • [1] The Effect of Birth Month on the Risk of Respiratory Syncytial Virus Hospitalization in the First Year of Life in the United States
    Lloyd, Patricia Calderon
    May, Larissa
    Hoffman, Daniel
    Riegelman, Richard
    Simonsen, Lone
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (06) : E135 - E140
  • [2] Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States
    Rohan C. Parikh
    Kimmie K. McLaurin
    Andrea V. Margulis
    Josephine Mauskopf
    Christopher S. Ambrose
    Melissa Pavilack
    Sean D. Candrilli
    [J]. Infectious Diseases and Therapy, 2017, 6 : 477 - 486
  • [3] Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States
    Parikh, Rohan C.
    McLaurin, Kimmie K.
    Margulis, Andrea V.
    Mauskopf, Josephine
    Ambrose, Christopher S.
    Pavilack, Melissa
    Candrilli, Sean D.
    [J]. INFECTIOUS DISEASES AND THERAPY, 2017, 6 (04) : 477 - 486
  • [4] Mortality Associated With Respiratory Syncytial Virus, Bronchiolitis, and Influenza Among Infants in the United States: A Birth Cohort Study From 1999 to 2018
    Reichert, Heidi
    Suh, Mina
    Jiang, Xiaohui
    Movva, Naimisha
    Bylsma, Lauren C.
    Fryzek, Jon P.
    Nelson, Christopher B.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (SUPPL 2): : S246 - S254
  • [5] Respiratory syncytial virus reinfections among infants and young children in the United States, 2011-2019
    Nduaguba, Sabina O.
    Tran, Phuong T.
    Choi, Yoonyoung
    Winterstein, Almut G.
    [J]. PLOS ONE, 2023, 18 (02):
  • [6] The Burden of Respiratory Syncytial Virus Lower Respiratory Tract Disease in Infants in the United States: A Synthesis
    Simoes, Eric A. F.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (SUPPL 2): : S143 - S147
  • [7] Impact of respiratory syncytial virus in the United States
    Robinson, Renee F.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (23) : S3 - S6
  • [8] Respiratory syncytial virus surveillance in the United States
    Lowther, SA
    Shay, DK
    Anderson, LJ
    [J]. PEDIATRIC RESEARCH, 2000, 47 (04) : 269A - 269A
  • [9] Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States
    La, Elizabeth M.
    Bunniran, Su
    Garbinsky, Diana
    Reynolds, Maria
    Schwab, Phil
    Poston, Sara
    Harrington, Lauriane
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [10] Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997-2006
    Stockman, Lauren J.
    Curns, Aaron T.
    Anderson, Larry J.
    Fischer-Langley, Gayle
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (01) : 5 - 9